Huaizhong Health Group, Inc.
ADAD · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 109.13 | 18.18 | 0.81 | -0.00 |
| FCF Yield | -0.10% | -0.08% | 0.00% | -1.73% |
| EV / EBITDA | 0.00 | 0.00 | 0.00 | -6.94 |
| Quality | ||||
| ROIC | 341.18% | 309.84% | 329.89% | 1,130.96% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.05 | 1.03 | -0.00 | 0.12 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% | -20.24% |
| Free Cash Flow Growth | 3.84% | -87,249.12% | 100.24% | -2,575.49% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | -0.08 |
| Interest Coverage | 0.00 | 0.00 | -75.16 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -264.97 |